ISSN: 2008-2258
Vol 14, No 1 (2021): Winter
Is gastric mapping needed in the endoscopy of dyspeptic patients?
Gastroenterology and Hepatology from Bed to Bench,
,
https://doi.org/10.22037/ghfbb.v14i1.1899
Abstract
Aim: Our study aimed to determine the prevalence of intestinal metaplasia in dyspeptic patients who underwent upper GI endoscopy.
Background: Intestinal metaplasia, which is defined as the replacement of normal gastric mucosa by metaplastic intestinal epithelium, has been described as a premalignant gastric lesion.
Methods: Six hundred two consecutive patients with dyspeptic symptoms who had undergone upper GI endoscopy were included in the study. For all patients, gastric mapping was performed to determine the presence of intestinal metaplasia. All histologic samples were reported according to the updated Sydney classification.
Results: Total of 61.3% of the patients were female. The mean age of the patients was 46±15 years. The overall prevalence of intestinal metaplasia was 22%. The distribution of intestinal metaplasia in the stomach was 15.1% in the antrum, 4.3% in the body, and 2.6% in the antrum and body together. Also, the prevalence of intestinal metaplasia in the age group of under 40 years was 9.5% and in patients over 40 years it was 29.5%..
Conclusion: The results of this study have shown that more than one-fifth of the patients with dyspepsia have intestinal metaplasia. This indicates that gastric mapping in patients with dyspepsia may lead to the detection of precancerous lesions especially after the age of 40.
Keywords: Dyspepsia, Gastric mapping, Intestinal metaplasia.
(Please cite as: Valizadeh Toosi SM, Sanayifar SF, Mohammadpour RA, Sheidaei S. Is gastric mapping needed in the endoscopy of dyspeptic patients?. Gastroenterol Hepatol Bed Bench 2021;14(1):31-35).
- Dyspepsia
- gastric mapping
- intestinal metaplasia
How to Cite
References
Zayeri F, Sheidaei A, Rahimzadeh S, Rezaei N, Modirian M, Baghestani AR, et al. Evaluation of the trends of stomach cancer incidence in districts of Iran from 2000-2010: Application of a random effects Markov Model. Asian Pac J Cancer Prev 2016;17:661-5.
Mousavi SK, Janbabai G, Kouchaki B, Borhani H, Rashidi M, Salehifar E. Demographic and clinical characteristics of gastric cancer patients in north of Iran, Mazandaran province, 2008-2014. Pharm Biomed Res 2015;1:32-6.
Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004:301-10.
Toh JW, Wilson RB. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int J Mol Sci 2020;21:6451.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
Moosazadeh M, Lankarani KB, Afshari M. Meta-analysis of the prevalence of Helicobacter pylori infection among children and adults of Iran. Int J Prev Med 2016;7.
Compare D, Rocco A, Nardone G. Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 2010;14:302-8.
Shafii M, Nikzad SE, Kasiri H, Naghipour M. Histopathological evaluation of chronic gastritis with and without Helicobacter pylori colonization: a study from Iran. Malays J Pathol 2008;30:27-30.
Correa P, Piazuelo MB. The gastric cancer. Colomb Medica 2013;44:192-201.
Craanen M, Dekker W, Blok P, Ferwerda J, Tytgat G. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16-20.
Eidt S, Stolte M. Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol 1994;29:607-10.
Petersson F, Borch K, Franzen L. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 2002;37:262-6.
Malekzadeh R, Sotoudeh M, Derakhshan M, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 2004;57:37-42.
Peleteiro B, Bastos J, Barros H, Lunet N. Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking. Gac Sanit 2008;22:236-46.
Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010;105:493.
Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gastroenterol Hepatol 2001;15.
Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda M, et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2000;15:1105-12.
Mabula JB, Mchembe MD, Koy M, Chalya PL, Massaga F, Rambau PF, et al. Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol 2012;10:257.
Eriksson N, Kärkkäinen PA, Färkkilä M, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008;40:355-60.
Ozdil K, Sahin A, Kahraman R, Yuzbasıoglu B, Demirdag H, Calhan T, et al. Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey. Hepato-gastroenterol 2010;57:1563-6.
Ajdarkosh H, Sohrabi M, Moradniani M, Rakhshani N, Sotodeh M, Hemmasi G, et al. Prevalence of gastric precancerous lesions among chronic dyspeptic patients and related common risk factors. Eur J Cancer Prev 2015;24:400-6.
Olmez S, Aslan M, Erten R, Sayar S, Bayram I. The prevalence of gastric intestinal metaplasia and distribution of Helicobacter pylori infection, atrophy, dysplasia, and cancer in its subtypes. Gastroent Res Pract 2015;2015.
Fuccio L, Zagari R, Minardi M, Bazzoli F. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharma Ther 2007;25:133-41.
Buxbaum JL, Hormozdi D, Dinis-Ribeiro M, Lane C, Dias-Silva D, Sahakian A, et al. Narrow-band imaging versus white light versus mapping biopsy for gastric intestinal metaplasia: a prospective blinded trial. Gastrointest Endosc 2017;86:857-65.
Bozorgnia MA, Kashfi SMH, Ariana M, Ghalkhani F, Iravani S, Lashkari MH, et al. Prevalence and correlation of chronic atrophic gastritis, intestinal metaplasia and other precancerous lesions of stomach in Iran: a historical cohort study. Clin Transl Gastroenterol 2015;4:413-22.
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times
